BPC
DVAX

Bryce Point Capital’s Dynavax Technologies DVAX Stock Holding History

Bryce Point Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,129
Closed -$259K – 194
2025
Q2 		$259K Buy
26,129
+555
+2% +$5.85K 0.22% 151
2025
Q1 		$357K Buy
+25,574
New +$338K 0.27% 156

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Bryce Point Capital's DVAX Position: Q3 2025 in Review

Bryce Point Capital sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 26,129 shares — an estimated $259K sold.

Bryce Point Capital first reported a position in DVAX in Q1 2025 and held it in 2 quarters. The position peaked at $357K in Q1 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Bryce Point Capital reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Bryce Point Capital sold 26,129 Dynavax Technologies shares in Q3 2025, an estimated $259K.
  • Bryce Point Capital first reported a position in Dynavax Technologies in Q1 2025 and held it in 2 quarters.
  • Bryce Point Capital's Dynavax Technologies position peaked at $357K in Q1 2025.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.